Hepatitis B Virus Prevalence among HIV-Uninfected People Living in Rural and Peri-Urban Areas in Botswana

Motswedi Anderson,Thabo Mangogola,Bonolo B. Phinius,Gorata Mpebe,Christopher O. Aimakhu,Wonderful T. Choga,Basetsana Phakedi,Lynnette N. Bhebhe,Doreen Ditshwanelo,Kabo Baruti,Linda Mpofu-Dobo,Lebogang Othusitse,Tsholofelo Ratsoma,Tendani Gaolathe,Joseph Makhema,Roger Shapiro,Shahin Lockman,Sikhulile Moyo,Simani Gaseitsiwe
DOI: https://doi.org/10.3390/microorganisms12061207
IF: 4.5
2024-06-15
Microorganisms
Abstract:(1) Background: we determined the prevalence of the hepatitis B virus (HBV) amongst people without human immunodeficiency virus (HIV) in rural and peri-urban areas in Botswana. (2) Methods: We screened for the hepatitis B surface antigen (HBsAg) from archived plasma samples of people without HIV (n = 2135) randomly selected from the Botswana Combination Prevention Program (BCPP) (2013–2018). We sequenced 415 bp of the surface region using BigDye sequencing chemistry. (3) Results: The median age of participants was 31 (IQR: 24–46) and 64% (1360/2135) were female. HBV prevalence was 4.0% (86/2135) [95% CI: 3.3–4.9]) and ranged between 0–9.2%. Older participants (>35 years) had increased odds of HBV positivity (OR: 1.94; 95% CI: [1.32–2.86]; p = 0.001). Thirteen samples were sequenced and seven (53.8%) were genotype A, three (23.1%) were genotype D and genotype E each. Clinically significant mutations were identified in the surface region, but no classic drug resistance mutations were identified. (4) Conclusions: We report an HBV prevalence of 4.0% (95% CI 3.3–4.9) among people without HIV in rural and peri-urban communities in Botswana with varying rates in different communities. A comprehensive national HBV program is required in Botswana to guide HBV prevention, testing and management.
microbiology
What problem does this paper attempt to address?